Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Our results document that active vitamin D3 reduced Salmonella colitis by decreasing inflammation, and bacterial translocation via induction of killing and autophagic clearance of pathogenic organisms.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Animal research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A Salmonella colitis model was established with 6 to 8‐week‐old male C57BL/6 mice: Streptomycin‐pretreated C57BL/6 mice were infected orally with Salmonella enterica serova Typhimurium wild‐type strain SL1344 for 48 h.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Active vitamin D3 attenuates the severity of Salmonella colitis in mice by orchestrating innate immunity
Study design awaiting verification · Immunity, Inflammation and Disease · 2021
Original publication title
Active vitamin D3 attenuates the severity of Salmonella colitis in mice by orchestrating innate immunity
© 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Salmonella spp. pose major public health problems worldwide. A better understanding of the pathogenesis of these foodborne pathogens is a prerequisite for the design of improved intervention strategies that could reduce the use of antimicrobial agents and drug‐resistant Salmonellosis. Accumulating evidence indicates that vitamin D is involved in regulating innate immunity, and may, therefore, play a key role in human responses to infection. Studies have suggested 1,25‐dihydroxyvitamin D3 (1,25D3), the active form of vitamin D, effectively ameliorates colitis. These findings have broad implications for the use of vitamin D compounds in colitis.
This study investigated the effect of active vitamin D3 on the severity of Salmonella colitis.
Source: IntroductionAbstract: What methods does the paper describe?
A Salmonella colitis model was established with 6 to 8‐week‐old male C57BL/6 mice: Streptomycin‐pretreated C57BL/6 mice were infected orally with Salmonella enterica serova Typhimurium wild‐type strain SL1344 for 48 h. The mice were randomly assigned to control, model, and 1,25(OH)2D3‐treated groups. After the experiment, the mice were sacrificed, and intestinal, spleen, and liver tissue samples were removed to analyze bacterial colonization, western blot for protein levels, and real‐time‐polymer chain reaction for messenger RNA (mRNA) expression.
Source: MethodsAbstract: Results
We observed that 1,25D3 reduced the severity of Salmonella colitis in C57BL/6 mice by reducing cecal mIL‐1beta, mIL‐6, mTNF‐alpha, and mIL‐8 mRNA expressions, bacterial colonization (CFU/mg tissue) in the liver and spleen, but increased the human β‐defensin‐2 mRNA and autophagy protein expression, compared to those of the SL1344 infection only.
Source: ResultsAbstract: Conclusions
Our results document that active vitamin D3 reduced Salmonella colitis by decreasing inflammation, and bacterial translocation via induction of killing and autophagic clearance of pathogenic organisms.
Source: ConclusionsAuthors’ abstract
Abstract
Introduction
Salmonella spp. pose major public health problems worldwide. A better understanding of the pathogenesis of these foodborne pathogens is a prerequisite for the design of improved intervention strategies that could reduce the use of antimicrobial agents and drug‐resistant Salmonellosis. Accumulating evidence indicates that vitamin D is involved in regulating innate immunity, and may, therefore, play a key role in human responses to infection. Studies have suggested 1,25‐dihydroxyvitamin D3 (1,25D3), the active form of vitamin D, effectively ameliorates colitis. These findings have broad implications for the use of vitamin D compounds in colitis.
This study investigated the effect of active vitamin D3 on the severity of Salmonella colitis.
Methods
A Salmonella colitis model was established with 6 to 8‐week‐old male C57BL/6 mice: Streptomycin‐pretreated C57BL/6 mice were infected orally with Salmonella enterica serova Typhimurium wild‐type strain SL1344 for 48 h. The mice were randomly assigned to control, model, and 1,25(OH)2D3‐treated groups. After the experiment, the mice were sacrificed, and intestinal, spleen, and liver tissue samples were removed to analyze bacterial colonization, western blot for protein levels, and real‐time‐polymer chain reaction for messenger RNA (mRNA) expression.
Results
We observed that 1,25D3 reduced the severity of Salmonella colitis in C57BL/6 mice by reducing cecal mIL‐1beta, mIL‐6, mTNF‐alpha, and mIL‐8 mRNA expressions, bacterial colonization (CFU/mg tissue) in the liver and spleen, but increased the human β‐defensin‐2 mRNA and autophagy protein expression, compared to those of the SL1344 infection only.
Conclusions
Our results document that active vitamin D3 reduced Salmonella colitis by decreasing inflammation, and bacterial translocation via induction of killing and autophagic clearance of pathogenic organisms.
Publication and source details
Original title: Active vitamin D3 attenuates the severity of Salmonella colitis in mice by orchestrating innate immunity
Fu‐Chen Huang; Shun‐Chen Huang
Immunity, Inflammation and Disease · 2021
* Correspondence Fu‐Chen Huang, Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123, Ta‐pei Rd, Niao‐sung District, Kaohsiung 833, Taiwan.Email: huang817@cgmh.org.tw
© 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Chang Gung Memorial Hospital 10.13039/100012553CMRPG860431CMRPG8H0681Ministry of Science and Technology, Taiwan 10.13039/501100004663MOST 106‐2314‐B‐182‐052MOST 107‐2314‐B‐182‐046‐MY2
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T13:21:40.184244+00:00
DOI: 10.1002/iid3.408 · PMC8127544